Murphy Wan

Murphy Wan is a postdoctoral fellow at the Faculty of Medicine, Lund University, affiliated with the Division of Microbiology, Immunology and Glycobiology (MIG) and Cancer Infection. Their research spans pharmacology, immunology, and oncology, focusing on natural compounds for disease prevention, host-pathogen interactions, and cancer therapies.

• Key Roles: Postdoctoral Fellow, Research Fellow
• Institution: Lund University, Sweden

Their work contributes to the UN Sustainable Development Goals, particularly in health and well-being (SDG 3) and life on land (SDG 15). Research interests include the pharmacokinetics of Schisandra chinensis lignans, modulation of immune responses by toxins like deoxynivalenol, and MYC inhibition mechanisms in disease.

Recent publications highlight investigations into:

• Schisandra chinensis lignans for disease prevention
• Deoxynivalenol's impact on mucin and cytokines
• Multitarget MYC inhibition by bacterial proteases
• Alpha1-oleate in bladder cancer treatment
• Drug interactions in colorectal cancer models

Collaborations extend across disciplines (immunology, microbiology, oncology) and geographies, with external partnerships in Europe, North America, and Asia. Their studies integrate molecular biology, clinical applications, and food science to address infectious and oncological challenges.